Jci_page_head_homepage_01 Jci_page_head_homepage_02
Hanna Huopio, Frank Reimann, Rebecca Ashfield, Jorma Komulainen, Hanna-Liisa Lenko, Jaques Rahier, Ilkka Vauhkonen, Juha Kere, Markku Laakso, Frances Ashcroft, Timo Otonkoski
Published in Volume 106, Issue 7
J Clin Invest. 2000; 106(7):897–906 doi:10.1172/JCI9804
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 4

Effects of metabolic inhibition on wild-type and mutant Kir6.2/SUR1 currents. Mean whole-cell current amplitudes recorded at –50 mV first in control solution (black bars), 15 minutes after exposure to 3 mM azide (hatched bars), then in the continued presence of azide plus 340 μM diazoxide (white bars), and, finally, after the further addition of 500 μM tolbutamide (shaded bars). Oocytes were co-injected with mRNA encoding Kir6.2 and either SUR1, SUR1-E1506K, or a 1:1 mixture of SUR1 plus SUR1-E1506K, as indicated. The number of oocytes is given above the error bars.